VibroSense Dynamics AB (publ) announces today that the company has signed a distribution agreement with Alpmed Tibbi Cihazlar, a medical device distributor active in the Turkish market. The agreement grants Alpmed the right to market and sell VibroSense products in Turkey, marking the company’s entry into the Turkish market.
Alpmed Tibbi Cihazlar is an established medical device distributor in Turkey with strong knowledge of the Turkish healthcare system and its procurement processes. Turkey is one of Europe’s and the Middle East’s most dynamic healthcare markets, with a population of over 85 million. The country has a rapidly growing diabetes population and an increasing focus on occupational health and neurological diagnostics, creating a natural demand for VibroSense Meter® II.
“Turkey is an exciting market with a large, growing healthcare system and a strong academic sector. We are pleased to welcome Alpmed as our distributor and are particularly encouraged by the early interest from Hacettepe University, where the VibroSense Meter II has been requested for use in a clinical study. This gives us an excellent foundation for building a strong presence in Turkey”, says Toni Speidel, CEO of VibroSense Dynamics AB.
For more information, please contact:
Toni Speidel, CEO
VibroSense Dynamics AB (publ)
Phone: +46 40 88 026
Email: info@vibrosense.com
Website: www.vibrosense.com
“The new Gold Standard for reliable
detection of nerve damage”
About VibroSense Dynamics AB (publ)
VibroSense Dynamics AB (publ) develops and sells medical devices and services to facilitate diagnosis of nerve damage in the hands and feet. The method is based on measuring and quantifying the ability to perceive vibrations applied to the skin at multiple frequencies. The company's customers include diabetes clinics, occupational health providers, hospitals, primary care centers, and researchers.
Our vision that the company's products shall become a standard tool in all neurological examinations, to detect early signs of sensory changes so that patients and healthcare providers can take preventive action to avoid, reduce, or delay the onset of nerve damage in the hands and feet.